Abstract
Primary systemic therapy (PST) is used in non-metastatic breast cancer to decrease tumour size and reduce the extent of surgery. This article reviews imaging and surgical issues associated with the increasing use of PST in the management of breast cancer. The role of imaging, with a special focus on ultrasound, is evaluated.
Get full access to this article
View all access options for this article.